Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5B | Q9Y2D0 | 6/20 | 0.55 |
| ▸ | CA12 | O43570 | 5/20 | 0.55 |
| ▸ | CA6 | P23280 | 5/20 | 0.55 |
| ▸ | CA7 | P43166 | 5/20 | 0.55 |
| ▸ | CA9 | Q16790 | 5/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.55 |
| ▸ | CA5A | P35218 | 5/20 | 0.55 |
| ▸ | CA3 | P07451 | 4/20 | 0.55 |
| ▸ | CA2 | P00918 | 4/20 | 0.55 |
| ▸ | CA4 | P22748 | 4/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8519355 | 1.00 | CA5B (0.55) | CA5BCA12CA6CA7CA9 | |
| SCHEMBL13756331 | 0.91 | CASP2 (0.59) | CA5BCA12CA6CA7CA9 | |
| SCHEMBL2240590 | 0.87 | CA3 (0.42) | CA5BCA12CA6CA7CA9 | |
| SCHEMBL322077 | 0.84 | — | — | |
| Trientine SCHEMBL20639324 | 0.84 | CA12 (0.69) | CA5BCA12CA6CA7CA9 | |
| Bicarbonate SCHEMBL10634656 | 0.84 | CA12 (0.69) | CA5BCA12CA6CA7CA9 | |
| Trientine SCHEMBL505672 | 0.82 | LMNA (0.58) | CA5BCA12CA6CA7CA9 | |
| SCHEMBL4412170 | 0.82 | CA5B (0.58) | CA5BCA12CA6CA7CA9 | |
| Succinic Acid SCHEMBL2447637 | 0.82 | LMNA (0.58) | CA5BCA12CA6CA7CA9 | |
| SCHEMBL27353046 | 0.82 | CA5B (0.58) | CA5BCA12CA6CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110628402-B | Cross-linking agent and organogel water shutoff agent, and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-110628402-A | Cross-linking agent and organogel water shutoff agent, and preparation method and application thereof | 中国石油化工股份有限公司 | 2019-12-31 | — | — | CN | claimed |
| CN-103396776-B | A kind of oil and water well self-generating foam unblocking agent and de-plugging process | XIAN PETROLEUM UNIV. (CN) | 2016-01-06 | — | — | CN | claimed |
| CN-103396776-A | Self-generating foam blocking removal agent for oil-water well and blocking removal process | UNIV XI AN SHIYOU | 2013-11-20 | — | — | CN | claimed |
| CN-114705804-B | Device and method for continuously measuring soluble carbon in soil or aqueous solution | 安徽师范大学 | 2024-08-23 | — | — | CN | disclosed |
| US-11998584-B2 | Conjugate of a tubulysin analog with branched linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2024-06-04 | — | — | US | disclosed |
| US-11873281-B2 | Conjugates of cell binding molecules with cytotoxic agents | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | CARMOT THERAPEUTICS, INC. | 2023-11-09 | — | — | US | disclosed |
| US-20230165930-A1 | CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230165931-A1 | A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230149502-A1 | CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-05-18 | — | — | US | disclosed |
| CN-115738600-A | Amino functional ion compound anhydrous absorbent for absorbing carbon dioxide and preparation method thereof | 安徽工业大学 | 2023-03-07 | — | — | CN | disclosed |
| EP-2678349-A1 | C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | Taisho Pharmaceutical Co., Ltd. (JP) | 2014-01-01 | — | — | EP | disclosed |
| CN-103396776-A | Self-generating foam blocking removal agent for oil-water well and blocking removal process | UNIV XI AN SHIYOU | 2013-11-20 | — | — | CN | disclosed |
| WO-2012115256-A1 | C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-08-30 | — | — | WO | disclosed |
| WO-2011147033-A2 | COMPOSITIONS AND METHODS FOR CAPTURING CARBON DIOXIDE | SAINT MARY'S UNIVERSITY (CA) | 2011-12-01 | — | — | WO | disclosed |
| CN-101537300-B | Recyclable sulfur dioxide gas absorbent and preparation method thereof | UNIV HEFEI TECHNOLOGY | 2011-08-10 | — | — | CN | disclosed |
| CN-101537300-A | Recyclable sulfur dioxide gas absorbent and preparation method thereof | UNIV HEFEI TECHNOLOGY | 2009-09-23 | — | — | CN | disclosed |
| US-5972038-A | METAL PHTHALOCYANINE PHOTOBLEACH COMPOUND; DIETHYLENE TRIAMINE PENTAACETATE, DIETHYLENE TRIAMINE PENTA(METHYLENE PHOSPHONATE), AND MIXTURES THEREOF. | THE PROCTER & GAMBLE COMPANY (US) | 1999-10-26 | — | — | US | disclosed |
| WO-1997031994-A1 | CHELANT ENHANCED PHOTOBLEACHING | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | GIPR, GLP1R, GCGR | CA5B 2330/4885CA12 2875/4885CA6 2445/4885 |
| US-20230165930-A1 | CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | TEKT1, CD2BP2, TEK | CA5B 2164/4885CA12 1484/4885CA6 2275/4885 |
| US-20230165931-A1 | A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | TEKT1, CD2BP2, CD4 | CA5B 2246/4885CA12 1484/4885CA6 2407/4885 |
| US-11873281-B2 | Conjugates of cell binding molecules with cytotoxic agents | CD4, CD2, CD47 | CA5B 2799/4885CA12 952/4885CA6 3056/4885 |
| US-11998584-B2 | Conjugate of a tubulysin analog with branched linkers | TEKT1, TEK, CD2BP2 | CA5B 1939/4885CA12 1235/4885CA6 2077/4885 |
| US-20230149502-A1 | CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS | TEKT1, CD2BP2, TEK | CA5B 2164/4885CA12 1484/4885CA6 2275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.